We have compiled reports detailing the patents and regulatory exclusivities protecting FDA-approved biologics in the United States.
The reports describe the patents by:
- patent number,
- claim coverage, and
- expiration date
The status of ongoing patent challenges are also described.
Regulatory exclusivities are described by type (data, orphan, and pediatric) and expiration date.
Follow-ons approved or in development are also reported.
